[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100266866":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":15,"locations":7,"responsibleParty":21,"collaborators":24,"id":38,"slug":39,"hasResults":40,"nctId":41,"briefTitle":42,"officialTitle":43,"acronym":7,"eligibilityCriteria":44,"healthyVolunteers":40,"sex":45,"minAge":7,"maxAge":46,"enrollmentInfo":47,"targetDuration":7,"studyType":50,"phases":7,"briefSummary":51,"conditions":52,"keywords":54,"overallStatus":56,"whyStopped":7,"lastUpdateSubmitDate":57,"lastUpdatePostDateStruct":58,"startDateStruct":60,"completionDateStruct":62,"leadSponsor":64,"locationsCount":7},{"fullName":5,"class":6},"Beijing Children's Hospital","OTHER",null,[9,13],{"name":10,"affiliation":11,"role":12},"Kunling Shen, MD, PhD","Beijing Children's Hospital of Capital Medical University, China, China National Clinical Research Center for Respiratory Diseases","PRINCIPAL_INVESTIGATOR",{"name":14,"affiliation":11,"role":12},"Baoping Xu, MD, PhD",[16],{"name":17,"role":18,"phone":19,"phoneExt":7,"email":20},"Baoping Xu, PhD","CONTACT","861059616308","xubaopingbch@163.com",{"type":12,"investigatorFullName":22,"investigatorTitle":23,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"Kunling Shen","Chief of China National Clinical Research Center for Respiratory Diseases",[25,27,29,31,34,36],{"name":26,"class":6},"Shengjing Hospital",{"name":28,"class":6},"Capital Institute of Pediatrics, China",{"name":30,"class":6},"Shanghai Children's Medical Center",{"name":32,"class":33},"Shenzhen Children's Hospital","OTHER_GOV",{"name":35,"class":6},"The First Affiliated Hospital of Xiamen University",{"name":37,"class":6},"First Affiliated Hospital of Guangxi Medical University","100266866","registry-study-on-cystic-fibrosis-in-chinese-children-100266866",false,"NCT02753374","Registry Study on Cystic Fibrosis in Chinese Children","Registry Study on Cystic Fibrosis in Chinese Children-a Multicenter, Prospective Cohort Study","Inclusion Criteria:\n\n* Age 0\\~18 years old\n* Any organ system symptoms consistent with CF, such as chronic sinopulmonary disease, gastrointestinal and nutritional abnormalities, obstructive azoospermia or having siblings with CF\n* CFTR dysfunction indicated by elevated sweat chloride levels ≥60 mmol\u002FL twice, or one sweat chloride levels ≥40 mmol\u002FL plus presence of two pathogenic CFTR mutations on different alleles\n* Probable CF patients with sweat chloride levels among 40\\~59 mmol\u002FL plus with presence of 0-1 pathogenic CFTR mutation\n* Consent to provide the related clinical specimen to the certain hospital\n* The guardians of the patients fully understand the purpose of the study, volunteer their children to participate in this study and sign informed consent.\n\nExclusion Criteria:\n\n* Subject will be excluded if she or he has one of the following:\n* It is unable to provide complete medical records or the current condition can not accept the diagnosis process.\n* She or he does not agree to participate in the test.","ALL","18 Years",{"count":48,"type":49},100,"ESTIMATED","OBSERVATIONAL","This study is a multicenter, prospective cohort study of patients diagnosed with cystic fibrosis, the clinical information of recruited patients, including clinical manifestations, lung function, chest imaging, quality of life and other indicators, will be followed for 10 years.",[53],"Cystic Fibrosis",[55],"cystic fibrosis, Chinese, children","NOT_YET_RECRUITING","2016-04-27",{"date":59,"type":49},"2016-04-28",{"date":61,"type":7},"2016-05",{"date":63,"type":49},"2030-07",{"name":5,"class":6}]